Back to search
FDAFDA · Food and drugs·Recall number Z-1902-2012

MULTIGENT Acetaminophen for use with Architect/Aeroset Cat. No. 2K99-20. Assay is intended for the quantitative determination of acetaminophen in human serum or plasma.

Published July 4, 2012 · Recall initiated: May 29, 2012

Summary

FDA records medical device Class II recall Z-1902-2012, published July 4, 2012 and initiated May 29, 2012. Recalling firm: Sekisui Diagnostics Llc; Status: Terminated; Reported quantity: 1600 kits; Lot: Lot 41928UQ11 {exp 2013-01 -31 ). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Discoloration of the acetaminophen enzyme reagent (R1), generates a high calibration factor and erratic control recovery.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sekisui Diagnostics Llc
Distributor
Illinois
Lot
Lot 41928UQ11 {exp 2013-01 -31 )
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was MULTIGENT Acetaminophen for use with Architect/Aeroset Cat. No. 2K99-20. Assay is intended for the quantitative determination of acetaminophen in human serum or plasma. recalled?

Yes. FDA published recall Z-1902-2012 on July 4, 2012. Reported hazard: Discoloration of the acetaminophen enzyme reagent (R1), generates a high calibration factor and erratic control recovery.

What should I do if I have this product?

Voluntary: Firm initiated · Letter